The lung interstitial macrophage has been relatively neglected in studies of pulmonary macrophages and remains poorly characterized. The importance of these cells is suggested by their substantial numbers, proliferative capacity and their central position within the active lesions of injured lungs. The capacity of alveolar macrophages to secrete proteolytic enzymes, inflammatory mediators, and factors that modulate fibroblasts has been well established. In contast, similar characterization of interstitial macrophages is lacking, despite the more intimate relationship of this cell to lung matrix, fibroblasts and endothelium. We have found that important antigenic distinctions between alveolar and interstitial macrophages exist and can be used to isolate viable, functionally intact populations of interstitial macrophages for further in vitro characterization. The role of these cells isolated from normal lungs will be defined by quantitating capacities relevant to normal lung defense mechanisms. The role of these cells in diseased lungs will be defined in relationships to the pathogenesis of various lung diseases, e.g., modulation of fibroblast proliferation, release of chemotactic factors, release of proteolytic enzymes. Regulation of interstitial macrophage proliferation will be studied using colony forming unit assays. Isolated interstitial macrophages will be studied in vitro to analyze differentiation to and acquisition of the alveolar macrophage phenotype. Parallel studies of both hamster and human lung tissue will be undertaken since we have found useful antigenic discriminants in both systems. By defining the structure, differentiation and function of isolated interstitial macrophages, these studies will clarify the role of these cells in normal lungs and in the pathogenesis of interstitial lung diseases. The candidate is ideally suited for this award because of his training, demonstrated research interest and commitment to an academic career as an independent investigator in pulmonary disease. The environment is an established laboratory with proven success in training individuals with interest in cellular mechanisms in respiratory biology. The full support of the sponsors and the available expertise in their affiliated departments will assure a comprehensive and productive training program, resulting in a well-rounded independent investigator in pulmonary disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard University
Schools of Public Health
United States
Zip Code
Huang, S; Paulauskis, J D; Kobzik, L (1992) Rat KC cDNA cloning and mRNA expression in lung macrophages and fibroblasts. Biochem Biophys Res Commun 184:922-9
Rose, R M; Kobzik, L; Dushay, K et al. (1992) The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates. Am Rev Respir Dis 146:1279-86
Rose, R M; Kobzik, L; Filderman, A E et al. (1992) Characterization of colony stimulating factor activity in the human respiratory tract. Comparison of healthy smokers and nonsmokers. Am Rev Respir Dis 145:394-9
Kobzik, L; Godleski, J J; Brain, J D (1990) Selective down-regulation of alveolar macrophage oxidative response to opsonin-independent phagocytosis. J Immunol 144:4312-9
Kobzik, L; Godleski, J J; Brain, J D (1990) Oxidative metabolism in the alveolar macrophage: analysis by flow cytometry. J Leukoc Biol 47:295-303
Kobzik, L; Godleski, J J; Barry, B E et al. (1988) Isolation and antigenic identification of hamster lung interstitial macrophages. Am Rev Respir Dis 138:908-14